Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Read more at CNBC
-
Bristol Myers’s stock pops as earnings top estimates and company raises guidance
Business - MarketWatch - 1 hour ago -
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Business - CNBC - Yesterday -
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Business - CNBC - 2 hours ago -
Citigroup earnings top estimates, but stock falls as bank boosts loan loss reserves
Business - CNBC - October 15 -
Comcast tops earnings estimates as Olympics propel the company
Business - CNBC - 6 minutes ago -
Samsung falls short of expectations as chipmaker fails to reap AI benefits
World - Financial Times - 7 hours ago -
Donald Trump and the autocrats' playbook
World - Financial Times - 8 hours ago -
UK Labour’s Budget borrows big, taxes more
World - Financial Times - 8 hours ago
More from CNBC
-
Super Micro's $50 billion stock collapse underscores risk of AI hype
Business - CNBC - 1 hour ago -
Comcast is exploring separation of cable networks business
Business - CNBC - 10 minutes ago -
Key Fed inflation rate hits 2.1% in September, as expected
Business - CNBC - 5 minutes ago -
Elon Musk seeks to move $1 million voter lottery lawsuit to federal court
Business - CNBC - 22 minutes ago -
Boeing strike will dent last jobs report before election
Business - CNBC - 11 minutes ago
Latest in Business
-
Jim Cramer's top 10 things to watch in the stock market Thursday
Business - CNBC - 5 minutes ago -
Key Fed inflation rate hits 2.1% in September, as expected
Business - CNBC - 5 minutes ago -
Comcast tops earnings estimates as Olympics propel the company
Business - CNBC - 6 minutes ago -
MicroStrategy’s Saylor on the strategy to load up on bitcoin and how investors should value it
Business - MarketWatch - 10 minutes ago -
Comcast is exploring separation of cable networks business
Business - CNBC - 10 minutes ago